UPC APP 23523/2024

—·EP2681034: Device and method for continuous generative production

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
CEAD B.V.
CEAD USA B.V.
Reps: Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Respondents
BEGO Medical GmbH
Reps: Philipp Neels (Eisenführ Speiser Rechts- und Patentanwälte, Hamburg)
Division: Paris CD
Judges: Maximilian Haedicke · Judge-Rapporteur
Technology: Pharmaceutical & Medical
Language: —
First decided: May 10, 2024

Decisions

2024-05-10
Generic application
Paris Central Division procedural order (judge-rapporteur Haedicke) in a revocation action by CEAD B.V. and CEAD USA B.V. against BEGO Medical GmbH concerning EP 2 681 034 B1, addressing a request by CEAD (as claimant in the Dutch-language revocation proceedings) for simultaneous interpretation into Dutch (alternatively English) at the interim hearing (29 May 2024) and oral hearing (23 August 2024). The court rejected the request for simultaneous interpretation under R. 109 VerfO, holding that the right to be heard is sufficiently protected where the party's authorised representative is fluent in the language of the proceedings (German). Simultaneous interpretation at the parties' own cost, however, was permitted.
Legal issues:Request for simultaneous interpretation (R. 109 VerfO / Art. 51(2) UPCA)Right to be heard vs. language of proceedings requirementsCourt-ordered vs. party-funded interpretation

Documents